Kronos Bio, Inc. (KRON)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Loading interactive chart…
- Simply Wall St.
Insider Spends US$3.1m Buying More Shares In Kronos Bio
Those following along with Kronos Bio, Inc. ( NASDAQ:KRON ) will no doubt be intrigued by the recent purchase of shares...
- Simply Wall St.
Here's Why We're Watching Kronos Bio's (NASDAQ:KRON) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- GlobeNewswire
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 continues to show dose linear pharmacokinetics up to 80mg three-days-on, four-days-off dose, including increased target engagement at the 80mg vs. 60mg doses — — The escalation cohort at 80mg four-days-on, three-days-off is currently enrolling, and the expansion cohort at this dose is expected to begin enrollment in the third quarter of 2024 — SAN MATEO, Calif. and C
© 2024 Yahoo. All rights reserved.